Oppenheimer Asset Management Inc. Sells 4,141 Shares of Hamilton Lane Incorporated (NASDAQ:HLNE)

Oppenheimer Asset Management Inc. lowered its stake in Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 9.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,677 shares of the company's stock after selling 4,141 shares during the period. Oppenheimer Asset Management Inc. owned approximately 0.07% of Hamilton Lane worth $5,578,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Wellington Management Group LLP boosted its holdings in shares of Hamilton Lane by 31.1% in the third quarter. Wellington Management Group LLP now owns 1,743,033 shares of the company's stock worth $293,509,000 after buying an additional 413,015 shares during the period. State Street Corp lifted its position in shares of Hamilton Lane by 53.7% in the 3rd quarter. State Street Corp now owns 1,401,909 shares of the company's stock valued at $236,516,000 after acquiring an additional 489,557 shares in the last quarter. Geode Capital Management LLC boosted its stake in Hamilton Lane by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,105,063 shares of the company's stock worth $186,111,000 after purchasing an additional 25,657 shares during the period. Principal Financial Group Inc. grew its position in Hamilton Lane by 20.2% during the 3rd quarter. Principal Financial Group Inc. now owns 583,721 shares of the company's stock worth $98,297,000 after purchasing an additional 97,924 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its stake in Hamilton Lane by 2.3% during the 4th quarter. Bank of New York Mellon Corp now owns 356,226 shares of the company's stock valued at $52,739,000 after purchasing an additional 7,932 shares during the period. Institutional investors and hedge funds own 97.40% of the company's stock.

Remove Ads

Hamilton Lane Stock Down 2.3 %

Shares of HLNE stock traded down $3.49 on Tuesday, hitting $149.10. The company's stock had a trading volume of 250,205 shares, compared to its average volume of 501,127. The stock has a market capitalization of $8.27 billion, a price-to-earnings ratio of 27.44 and a beta of 1.25. Hamilton Lane Incorporated has a fifty-two week low of $103.42 and a fifty-two week high of $203.72. The firm's fifty day moving average price is $154.00 and its 200-day moving average price is $165.28. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.19 and a quick ratio of 4.19.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $1.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.12. Hamilton Lane had a return on equity of 36.69% and a net margin of 31.12%. The company had revenue of $168.26 million during the quarter, compared to the consensus estimate of $158.86 million. During the same quarter in the prior year, the company posted $0.71 EPS. The firm's revenue was up 34.3% on a year-over-year basis. Research analysts anticipate that Hamilton Lane Incorporated will post 4.97 EPS for the current year.

Hamilton Lane Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 4th. Stockholders of record on Friday, March 14th will be given a $0.49 dividend. This represents a $1.96 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date of this dividend is Friday, March 14th. Hamilton Lane's dividend payout ratio is 36.16%.

Analyst Ratings Changes

HLNE has been the subject of several recent analyst reports. Keefe, Bruyette & Woods raised their target price on Hamilton Lane from $158.00 to $168.00 and gave the stock a "market perform" rating in a research report on Wednesday, February 5th. Wells Fargo & Company upped their price objective on shares of Hamilton Lane from $163.00 to $169.00 and gave the company an "equal weight" rating in a research note on Wednesday, February 5th. Morgan Stanley lifted their target price on shares of Hamilton Lane from $182.00 to $190.00 and gave the company an "equal weight" rating in a research note on Monday, November 11th. JPMorgan Chase & Co. boosted their price target on shares of Hamilton Lane from $134.00 to $175.00 and gave the company a "neutral" rating in a report on Thursday, November 7th. Finally, The Goldman Sachs Group lowered Hamilton Lane from a "neutral" rating to a "sell" rating and set a $139.00 price objective for the company. in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $173.14.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.